학술논문
Successful Therapy Reduction in NCI Standard Risk (SR) Highly Favorable Subgroup of Childhood Acute Lymphoblastic Leukemia
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:42-43
Subject
Language
ISSN
0006-4971